This document provides information on chronic obstructive pulmonary disease (COPD). It begins with an introduction stating that COPD is a progressive and partially reversible disease comprising chronic bronchitis and emphysema. It then discusses the incidence and prevalence of COPD in the United States. Next, it describes the signs and symptoms of chronic bronchitis and emphysema. It concludes by outlining the diagnostic tests, complications, medical management including medications and lifestyle changes, and nursing management of COPD.
Pneumonia is an inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses.
Pneumonitis is a more general term that describes the inflammatory process in the lung tissue that may predispose and Pneumonia is an inflammation of the lung parenchyma that is caused by a microbial agent.
place the patient at risk for microbial invasion.
Pneumonia is classified into four: community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), pneumonia in the immunocompromised host, and aspiration pneumonia.
Chronic obstructive pulmonary disease (COPD)- Preeti sharmaEducate with smile
COPD is a type of obstructive lung disease and related conditions. it is very helpful presentation to you about information of COPD.
It includes all things that is definition, causes, symptoms, pathophysiology, diagnostic evaluation, types, treatment and role of nurses for COPD patient.
Pneumonia is an inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses.
Pneumonitis is a more general term that describes the inflammatory process in the lung tissue that may predispose and Pneumonia is an inflammation of the lung parenchyma that is caused by a microbial agent.
place the patient at risk for microbial invasion.
Pneumonia is classified into four: community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), pneumonia in the immunocompromised host, and aspiration pneumonia.
Chronic obstructive pulmonary disease (COPD)- Preeti sharmaEducate with smile
COPD is a type of obstructive lung disease and related conditions. it is very helpful presentation to you about information of COPD.
It includes all things that is definition, causes, symptoms, pathophysiology, diagnostic evaluation, types, treatment and role of nurses for COPD patient.
Emphysema is a type of COPD involving damage to the air sacs (alveoli) in the lungs. As a result, your body does not get the oxygen it needs. Emphysema makes it hard to catch your breath. You may also have a chronic cough and have trouble breathing during exercise. The most common cause is cigarette smoking
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to describe progressive lung diseases including emphysema, chronic bronchitis, and refractory (non-reversible) asthma. This disease is characterized by increasing breathlessness
Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities (more than 2 cm) containing necrotic debris or fluid caused by microbial infection.
Pleural effusion, sometimes referred to as “water on the lungs,” is the build-up of excess fluid between the layers of the pleura outside the lungs. The pleura are thin membranes that line the lungs and the inside of the chest cavity and act to lubricate and facilitate breathing.
TOPIC: Nursing Management of Br.Asthma
المحاضر: فريدة محمد مصطفى (مشرفه التعليم الطبي بالتمريض)
SPEAKER: Sr.Fareedah M. Mustafa
( Nursing Education Coordinator , MGH)
Chronic obstructive pulmonary disorders COPD is a [preventable and treatable disease with some significant extra pulmonary effects that may contribute to the severity in individual clients.
It is characterized by airflow limitation that is not completely reversible.
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
Rheumatic heart disease is a condition in which the heart valves have been permanently damaged by rheumatic fever. The heart valve damage may start shortly after untreated or under-treated streptococcal infection such as strep throat or scarlet fever.
Emphysema is a type of COPD involving damage to the air sacs (alveoli) in the lungs. As a result, your body does not get the oxygen it needs. Emphysema makes it hard to catch your breath. You may also have a chronic cough and have trouble breathing during exercise. The most common cause is cigarette smoking
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to describe progressive lung diseases including emphysema, chronic bronchitis, and refractory (non-reversible) asthma. This disease is characterized by increasing breathlessness
Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities (more than 2 cm) containing necrotic debris or fluid caused by microbial infection.
Pleural effusion, sometimes referred to as “water on the lungs,” is the build-up of excess fluid between the layers of the pleura outside the lungs. The pleura are thin membranes that line the lungs and the inside of the chest cavity and act to lubricate and facilitate breathing.
TOPIC: Nursing Management of Br.Asthma
المحاضر: فريدة محمد مصطفى (مشرفه التعليم الطبي بالتمريض)
SPEAKER: Sr.Fareedah M. Mustafa
( Nursing Education Coordinator , MGH)
Chronic obstructive pulmonary disorders COPD is a [preventable and treatable disease with some significant extra pulmonary effects that may contribute to the severity in individual clients.
It is characterized by airflow limitation that is not completely reversible.
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
Rheumatic heart disease is a condition in which the heart valves have been permanently damaged by rheumatic fever. The heart valve damage may start shortly after untreated or under-treated streptococcal infection such as strep throat or scarlet fever.
COPD the condition is also know as chronic obstructive pulmonary disorder case study. This is winning case study presentation for Just for hearts case study competition. Refer to these slides to know more about this case.
Reading material on COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) for Nursing students and teachers. It tells pathophysiology, clinical manifestations, diagnostic evaluations, medical and nursing management of COPD.
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation that is slowly progressive. It is also known as Chronic obstructive lung disease. “(COLD)”
It refers to Chronic Bronchitis and emphysema, a pair of two commonly coexisting disease of the lungs in which the airways become narrowed.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. INTRODUCTION
COPD is the progressive and partially reversible
disease of the airway
Comprises primarily of two related disease-
chronic bronchitis and Emphysema
Chronic obstruction of the flow of air through
the airway and out of the lungs permanent and
progressive obstruction over time
3. INCIDENCE
COPD is the 5th leading cause of death in the
United States for all ages and both genders; fifth
for men and fourth for women
Men were found to have a prevalence of 11.8% and
women 8.5%. The numbers vary in different
regions of the world
more than 12,000 persons died of COPD. The
middle adult years, and the incidence of COPD
increases with age Chronic bronchitis
4. CONTD
Chronic bronchitis is defined clinically as a daily
cough with production of sputum at least 3 month
per year for 2 or more consecutive year.
It involves inflammation and swelling of the lining
of the air way that leads to narrowing and
obstruction of the air way.
The inflammation also stimulate production of
mucus which can cause further obstruction of the
airway.
5. EMPHYSEMA
It is permanent enlargement of the alveoli due to
destruction of the wall between alveoli which
leads to reduce the elasticity of the lungs over all.
Loss of elasticity leads to collapse of the
bronchioles, obstructing air flow out of the
alveoli. Air become trapped to the alveoli and
reduce the ability of the lungs to shrink during
exhalation .
6. CONTD
Reduce the expansion of the lungs during the next
breath reduce the amount of air that is inhaled
As a result, less air for the exchange of gasses
gets in to the lungs .
This trapped air also can compress adjacent less
damage lung tissue.
7. ETIOLOGY AND RISK
FACTORS
The specific causes of COPD are not clearly
understood. Some risk factors are tissue.
1.Cigarette smoking. The primary cause is exposure
to tobacco smoke. cigarette smoking will develops
COPD in 15% .Overall, tobacco smoking accounts
for as much as 90% of the risk of COPD .
Secondhand smoke
8. contd
Secondhand smoke, or environmental tobacco
smoke, increases the risk of respiratory
infections.
2.Air Pollution
outdoor air pollution contributes to the
development of COPD.
most common cause is indoor stoves for cooking
Some occupational pollutants such as cadmium and
silica-
9. contd
3.Alpha-1 Antitrypsin (AAT) deficiency-
AAT enzyme is produced by liver and present in
normal lungs. Normal1.5-3.5 g/l. Block the
damaging effects of elastase on elastin.
4. Chronic Respiratory Infections
5. Alcohol Ingestion
10. PATHOPHYSIOLOGYChronic inflammation
Increase number of goblet cell and
mucus secreation
Increase size and number of
submucus gland in bronchi and
mucus production
Decrease cillary function reduce mucus
clearance (deposit )mucus
Allergic reaction
IgE stimulation
IgE attached to the
mast cell
Mast cell release histamine
and prostagladin
Mucus secretion and
bronchospasm
Bronchi constriction
Obstructive air
way
11. SIGN AND SYMPTOMS
Cough, with or without mucus
Chronic cough and sputum production (in chronic bronchitis
Shortness of breath (dyspnea) that gets worse with mild
activity
Trouble catching one's breath
Fatigue
Wheezing
Rhonchi, decreased intensity of breath sounds, and
prolonged expiration on physical examination
chest tightness and tiredness
People with advanced COPD sometimes develop respiratory
failure
12. Common signs are:
Tachypnea a rapid breathing rate
Wheezing sounds or crackles in the lungs heard
through a stethoscope
Breathing out taking a longer time than breathing
in
Enlargement of the chest, particularly the front-
to-back distance (hyperaeration)
breathing through pursed lips
Increased anteroposterior to lateral ratio of the
chest (i.e. barrel chest)
13. INVESTIGATION
Medical History
Physical examination finds enlarged chest cavity
and wheezing.
Blood Test
A hematocrit value of more than 52% in males and
more than 47% in female indicates disease.
Measure the alpha1-antitrypsin (AAT),the AAT
level is low
14. contd Sputum for culture and microscopic examination
mucoid sputum .
The pathogens Streptococcus pneumoniae and
Haemophilus influenzae
19. contd
High Resolution CT scanning(HRCT): is highly specific
for diagnosing emphysema, and the outlined bullae
are not always visible on a radiograph.
CT scan (COPD)
Two-dimensional echocardiography may be helpful as
a screening tool to estimate pulmonary arterial
systolic pressure and right ventricular systolic
function.
20. CONT
Pulmonary Function Test
Forced expiratory volume in 1 second (FEV1) is a
reproducible test and is the most commonly
used index of airflow obstruction.
Mild= FEV1 >80% predicted
Moderate= FEV1 80-50% predicted
Sever= FEV1 50-30% predicted
Very sever = FEV1 <30% predicted
21. contd
Arterial blood gas analysis:
As the disease progresses, severe hypoxemia and
hypercapnia.
22. contd
Hypercapnia commonly is observed as the FEV1
falls below 1 L/s or 30% of the predicted value
Lung volume measurements often show an
increase in total lung capacity, functional residual
capacity, and residual volume.
The vital capacity often decreases
23. contd
Tidal Volume (TV):
volume of air inhaled or exhaled with each breath during
quiet breathing
Total Lung Capacity (TLC):
Sum of all volume compartments after maximum
inspiration
24. contd
Inspiratory Reserve Volume :
maximum volume of air inhaled from the end-
inspiratory tidal position
Expiratory Reserve Volume :
maximum volume of air that can be exhaled from
resting end-expiratory tidal position
25. COMPLICATIONS OF COPD
Respiratory Infections
Acute Respiratory Failure
Spontaneous Pneumothorax due to rupture of
emphysematous bleb.
Ventilation Perfusion Mismatch
Hypoxemia
Corpulmonale
26. Medical management
The treatment goal for the client with COPD is
To improve ventilation
To facilitate the removal of bronchial secretions
To prevent complications
To slow the progression of clinical manifestations
To promote health maintenance and client
management of disease.
27. Treatment strategies include
Quitting cigarette smoking
Taking medications to dilate airways(
bronchodilators)
Vaccinating against flu influenza and pneumonia
Regular oxygen supplementation
Pulmonary rehabilitation
28. MEDICAL MANAGEMENT
Quitting cigarette smoking: most important
treatments for COPD.
Patients who continue to smoke have a more rapid
deterioration in lung function when compared to
others who quit.
If one stops smoking, the decline in lung function
eventually reverts to that of a non- smoker
29. contd
Bronchodilators: Beta2 agonists are the most
frequently prescribed. (albuterol or salbutamol,
metaproterenol) have minimal adverse effects, rapid
onset of action
Anticholinergic : bronchodilators work by blocking the
cholinergic receptors resulting in bronchodilatation.(
Atrovent) is the most commonly used drug in this
category.
Methylxanthines(theophylline, aminophylline) are also
used to treat acute exacerbations.
30. contd It is helpful for the patient with COPD who have
heart failure and pulmonary hypertension.
Corticosteroids are used in the acute management of
clients with COPD exacerbations
Inhaled corticosteroids like Beclomethasone
diproprionate, salmeterol and fluticasone are used.
31. contd
Regular oxygen therapy: Regular oxygen therapy
is required when the client has severe exertion or
resting hypoxemia (pao2 < 40mm of Hg). Oxygen
(1-3L) by nasal canula may be required to raise the
pao2 to no less than 60mm of Hg. (normal 80-100
mm of Hg)
32. CONTD
Postural drainage and chest physiotherapy they
can be help expelled secretion.
Control complications: Edema and corpulmonale
are treated with diuretics and digitalis.
Phlebotomy also reduces cardiac workload.
Antibiotic- Treat with antibiotic therapy for
recurrent bacterial infection.
33. CONTD
Promote exercise- Aerobic exercise :Exercise
does not improve lung function more effectively
but strengthen the respiratory muscles even the
lungs are diseased.
Progressively increased walking is the most
common form of exercise.
Encourage diaphragmatic breathing and pursed-lip
breathing.
34. contd
Improve general health- The most effective way to slow disease
progression is for the client
to stop smoking
avoid exposure to known allergens
avoid high altitudes
Use supplemental O2 for air travel.
Adequate nutrition is essential to maintain respiratory muscle
strength.
Regular O2 therapy should be maintained.
35. NURSING MANAGEMENT
Assessment
Assessment :
history of smoking, family history, occupational
history
ABG analysis
respiratory rate, depth and characteristics
sputum amount and type
anxiety level of the patient
36. contd
1.Nursing Diagnosis: Impaired gas exchange
related to dyspnoea, mucus plug and decreased
ventilation
Goal: Client will be demonstrated improved
ventilation and adequate oxygenation .
Nursing intervention
Assess respiratory rate, depth, note use of
accessory muscles, pursed lip breathing, inability
to speak.
37. CONTD
Elevate head of bed, assist patient to assume
position to ease work of breathing.
Encourage deep slow or pursed lip breathing as
individually tolerated.
Administer low- flow oxygen therapy (1-2lit/min)
as needed via nasal prongs.
Administer bronchodilators if ordered
Regularly monitor the client's respiratory rate
and pattern, pulse oximetry, ABG results.
38. contd
2.Nursing Diagnosis: Activity intolerance related to
inadequate oxygenation and dyspnea
Nursing Goals: The client will have improved
activity tolerance within hospitalization period
39. CONTD
Nursing Intervention
Monitor the severity of dyspnea and oxygen
saturation with and following activity
Keep the patient in semi- flower position.
Maintain supplemental oxygen therapy (2lit/min)
Assist the client in scheduling a gradual increase
in daily activity and exercise
40. contd
Advise the client to avoid conditions that increase
oxygen demand such as temperature extremes,
excess weight and stress.
Instruct the client energy conservation
techniques such as pacing activities throughout
day.
Teach the client to use pursed-lip and
diaphragmatic breathing techniques
41. CONTD
3.Nursing Diagnosis: Ineffective airway clearance
related to excessive production of secretions,
retained secretions and ineffective coughing
Goal: The client will be maintain patent airway with
breath sounds clear within hospitalization
Nursing Intervention
Monitor respiratory rate and auscultate breath
sounds eg. wheeze, crackles, rhonchi
Assist the patient to assume position of comfort eg
elevate head of bed, sitting on edge of bed.
42. contd
Keep environmental pollution to minimum eg dust,
smoke and feather pillows according to individual
situation
Encourage/ assist with abdominal or pursed lip
breathing exercises
Administer medications as indicated such as
bronchodilators
Perform chest physiotherapy.
43. contd
4.Nursing Diagnosis: Anxiety related to disease
prognosis
Nursing goal: Patient will not have any more anxiety
after nursing intervention
44. contdNursing Intervention
Provide care in a calm and quiet environment.
Encourage the use of breathing retraining and
relaxation techniques.
Explain the patient about disease including
cause, signs and symptoms, medication,
procedures, prevention and follow up care
Give the opportunity to talk the patient with
similar problem who admitted in the same
ward and almost in recovery phase.
45. contd
5.Nursing Diagnosis: Risk for infection related to
ineffective pulmonary clearance
Goal: Client will have a decreased risk of infection
related to ineffective pulmonary clearance after
intervention
Nursing Intervention
Teach the client to wash his or her hands after
contact with potentially infectious material.
Teach the client and family how to care for and clean
respiratory equipment used at home.
46. CONTD
Assess vital signs including temperature and sputum
color, odor and character.
Teach the client and family the manifestations of
pulmonary infections like change in color or volume of
sputum, fever, chills, malaise, productive cough,
confusion, increased dyspnea etc
Discuss need for adequate nutritional intake
Explain client about the importance of self care
Notify the physician if any sign of infections occurs.